AARTI INDUSTRIES LTD. - 524208 - Aarti Industries And Deepak Fertilisers Signs A Binding Term-Sheet For Offtake And Supply Of Nitric Acid For A 20 Years Period
Aarti Industries and Deepak Fertilisers signs a binding term-sheet for offtake and supply of Nitric Acid for a 20 years period
Hold Aarti Industries; target of Rs 730: Sharekhan
Sharekhan recommended Hold rating on Aarti Industries with a target price of Rs 730 in its research report dated November 16, 2022.
Results Earnings Call for Q2FY23 of Aarti Industries
Conference Call with Aarti Industries Management and Analysts on Q2FY23 Performance and Outlook. Listen to the full earnings transcript. AARTI INDUSTRIES LTD. - 524208 - Recording Of Conference Call
Recording of Conference Call Q2FY23 Quarterly Result Announced for Aarti Industries Ltd.
Specialty chemical firm Aarti Industries announced Q2FY23 results: Q2FY23: Revenues of Rs 1,847 crore; an increase of 29% over the previous year EBITDA of Rs 267 crore; an increase of 5% over the previous year PAT of Rs 124 crore Rajendra Gogri, Chairman & MD at Aarti Industries Ltd, said: “Q2 of the current fiscal year has been an eventful period for us. Not only have we delivered a stable financial performance, but also received NCLT approval to demerge our Pharma business into a separate entity – Aarti Pharmalabs Limited, thereby significantly enhancing value for our stakeholders while also achieving operational efficiencies. This will help the companies take appropriate strategic decisions in view of the growth opportunities available under the respective businesses. The external environment continues to be challenging aggravated by high costs both on raw materials and utilities side, moderate slowdown in some end-user industries related to textiles combined with severe forex fluctuations and other global uncertainties. Against this backdrop, our performance has been resilient. Stability in performance over the years is an outcome of robust proficiency achieved in handling multiple chemistries with manufacturing excellence. Our execution capabilities and delivery commitments are best-in-class, and our customers trust us for that. We remain the go-to players for them when it comes to chemistries linked to Benzene and Toluene product chains among others. Our capex initiatives are well on track, and this will steer the performance momentum in the forthcoming period. Work is underway to create newer chemical value chains and also introduce high-potential products to expand the addressable market opportunity while catering to increased demand from key customers. We expect full benefit of our expansion program to unfold in FY24 and FY25 as we anticipate demand recovery from Q4 of the current fiscal year. Further, with the volume ramp-up for the new capacities coming in significantly in FY24 and FY25, while fixed costs will generally not increase significantly, the gross profit to EBITDA conversion will improve in FY24 and beyond We will continue to remain agile, while capitalising on opportunities created through swift movement in the Indian chemical industry landscape. Our R&Dp-led; product profile combined with incremental gains from existing value-chains will set the tone and improve our value proposition going ahead.” Result PDF AARTI INDUSTRIES LTD. - 524208 - Announcement under Regulation 30 (LODR)-Change in Directorate
Change in designation from Executive Director to Non-Executive Director AARTI INDUSTRIES LTD. - 524208 - Announcement under Regulation 30 (LODR)-Investor Presentation
Please find enclosed herewith the Q2 FY23 Results Presentation of the Company for your records. AARTI INDUSTRIES LTD. - 524208 - Audited Financial Results For The Quarter And Half Year Ended September 30, 2022
Audited Financial Results for the quarter and half year ended September 30, 2022 AARTI INDUSTRIES LTD. - 524208 - Board Meeting Outcome for Audited Financial Results For The Quarter And Half Year Ended September 30, 2022
Audited Financial Results for the quarter and half year ended September 30, 2022
